Cardiovascular Systems () EBITDA US GAAP (year values)

2019 2020 2021 2022   LTM ?
EBITDA, bln rub ? -0.825 -25.5 -10.7 -34.5   -35.6
Changes by years, y/y, % -137% +2 996% -58% -100%    

Cardiovascular Systems. EBITDA US GAAP, bln rub

Cardiovascular Systems. EBITDA US GAAP, changes, %

Cardiovascular Systems. EBITDA US GAAP, sum by quarters, bln rub

Cardiovascular Systems () EBITDA US GAAP (quarter values)

2022Q1 2022Q3 2022Q4 2023Q1 2023Q2   LTM ?
EBITDA, bln rub ? -9.59 -9.30 -9.14 -9.02 -8.18   -35.6
Changes by years, y/y, % +1 878% +108% +151% -6%    
Changes by quarters, q/q, % +33% -3% -2% -1% -9%    

Cardiovascular Systems. EBITDA US GAAP, bln rub

Cardiovascular Systems. EBITDA US GAAP, changes, y/y, %

Cardiovascular Systems. EBITDA US GAAP, changes, q/q, %